Abstract
Background
Oral iron is commonly prescribed to older patients with suspected or confirmed iron-deficiency anaemia; however, few studies have examined the effectiveness of oral iron therapy in the real world in this population. We therefore determined the prevalence of iron deficiency in older people prescribed oral iron, examined the response mounted to therapy and ascertained predictors of response to oral iron.
Methods
We analysed a routinely collected, linked dataset from older patients who had undergone inpatient rehabilitation between 1999 and 2011. An initial analysis examined patients within this cohort who were prescribed iron after rehabilitation and derived three groups based upon their ferritin and transferrin indices: probably, possibly and not iron deficient. A second analysis compared pre- and post-treatment haemoglobin to determine the degree of response to iron therapy across each category of deficiency. Finally, patient demographics, linked biochemistry data and comorbid disease based on International Classification of Disease (ICD-10) codes from previous hospital admissions were used in regression modelling to evaluate factors affecting response to therapy.
Results
A total of 490 patients were prescribed oral iron within 90 days of rehabilitation discharge. Of these, 413 (84 %) had iron indices performed; 94 (23 %) were possibly deficient, 224 (54 %) were probably deficient, and 95 (23 %) were not deficient. Of the 490 patients, 360 had both pre- and post-treatment haemoglobin data and iron indices; probably deficient patients mounted a slightly greater response to oral iron (17 vs. 12 g/L for not deficient; p < 0.05). Only pre-treatment haemoglobin, mean cell volume and lower gastrointestinal pathology were significant predictors of a response to oral iron therapy. Notably, acid-suppressant use was not a predictor of response.
Conclusion
We conclude that many older patients are exposed to oral iron without good evidence of either iron deficiency or a significant response to therapy.
References
Price EA, Mehra R, Holmes TH, et al. Anemia in older persons: etiology and evaluation. Blood Cells Mol Dis. 2011;46(2):159–65 (Elsevier Inc.).
Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104(8):2263–8 (American Society of Hematology).
Geisel T, Martin J, Schulze B, et al. An etiologic profile of anemia in 405 geriatric patients. Anemia. 2014;2014:932486.
Goodnough LT, Schrier SL. Evaluation and management of anemia in the elderly. Am J Hematol. 2014;89(1):88–96.
Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832–43.
Röllig C, Knop S, Bornhäuser M. Multiple myeloma. Lancet (London, England). 2015;385(9983):2197–208.
Klepin HD. Myelodysplastic syndromes and acute myeloid leukemia in the elderly. Clin Geriatr Med. 2016;32(1):155–73.
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–23.
Ferrucci L, Guralnik JM, Bandinelli S, et al. Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol. 2007;136(6):849–55.
Makipour S, Kanapuru B, Ershler WB. Unexplained anemia in the elderly. Semin Hematol. 2008;45(4):250–4.
Goddard AF, James MW, McIntyre AS, et al. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60(10):1309–16.
Lopez A, Cacoub P, Macdougall IC, et al. Iron deficiency anaemia. Lancet (London, England). 2016;387(10021):907–16.
Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101(7):2461–3.
Tolkien Z, Stecher L, Mander AP, et al. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117383.
Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: beers criteria-based review. Ann Pharmacother. 2000;34(3):338–46.
Levey AS, Coresh J, Greene T, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766–72.
National Institute of Diabetes and Digestive and Kidney Diseases. Creatinine standardization recommendations [Internet]. 2015 [cited 2015 Nov 6]. Available from: http://www.niddk.nih.gov/health-information/health-communication-programs/nkdep/lab-evaluation/gfr/creatinine-standardization/recommendations/Pages/recommendations.aspx.
Ejaz H, Muhammad A, Masood A, et al. Evaluation of serum transferrin receptor concentration in diagnosing and differentiating iron deficiency anaemia from anaemia of chronic disorders. J Pak Med Assoc. 2005;55(1):1–4.
WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity [Internet]. Vitamin and mineral nutrition information system. Geneva: World Health Organisation; 2011 [cited 2016 Jun 14]. Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdf.
Button LA, Roberts SE, Evans PA, et al. Hospitalized incidence and case fatality for upper gastrointestinal bleeding from 1999 to 2007: a record linkage study. Aliment Pharmacol Ther. 2011;33(1):64–76.
Scottish Care Information—Diabetes Collaboration. SCI-Diabetes [Internet]. 2015. [cited 2015 Nov 6]. Available from: http://www.sci-diabetes.scot.nhs.uk/.
Van Wyck DB, Mangione A, Morrison J, et al. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion. 2009;49(12):2719–28.
Thomas DW, Hinchliffe RF, Briggs C, et al. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol. 2013;161(5):639–48.
Okam MM, Koch TA, Tran M-H. Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials. Haematologica. 2016;101(1):e6–7.
Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut. 2000;46(Suppl IV):iv1–5.
Pang W, Schrier S. Anaemia in the elderly. Curr Opin Haematol. 2012;19:133–40.
Lam AP, Gundabolu K, Sridharan A, et al. Multiplicative interaction between mean corpuscular volume and red cell distribution width in predicting mortality of elderly patients with and without anemia. Am J Hematol. 2013;88(11):E245–9.
Tay HS, Soiza RL. Systematic review and meta-analysis: what is the evidence for oral iron supplementation in treating anaemia in elderly people? Drugs Aging. 2015;32(2):149–58.
Fairweather-Tait SJ, Wawer A, Gillings R, et al. Iron status in the elderly. Mech Ageing Dev. 2014;136–137:22–8 (Elsevier Ireland Ltd).
Kotzé A, Harris A, Baker C, et al. British Committee for Standards in Haematology Guidelines on the identification and management of pre-operative anaemia. Br J Haematol. 2015;171(3):322–31.
Padhi S, Kemmis-Betty S, Rajesh S, Guideline Development Group, et al. Blood transfusion: summary of NICE guidance. BMJ. 2015;351:h5832 (British Medical Journal Publishing Group).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The linked datasets used in this study were made possible by grant funding from the Scottish Government (grant number SPCH/10).
Conflict of interest
Zach Thomson, Katherine Hands and Miles Witham declare that they have no conflicts of interest relevant to the content of this study.
Rights and permissions
About this article
Cite this article
Thomson, Z., Hands, K.J. & Witham, M.D. Targeting, Monitoring and Effect of Oral Iron Therapy on Haemoglobin Levels in Older Patients Discharged to Primary Care from Inpatient Rehabilitation: A Cohort Study Using Routinely Collected Data. Drugs Aging 33, 603–610 (2016). https://doi.org/10.1007/s40266-016-0385-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-016-0385-y